- Home
- BUR vs CRNX Comparison
BUR vs CRNX Comparison
Compare BUR & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUR
- CRNX
- Stock Information
- Founded
- BUR 2009
- CRNX 2008
- Country
- BUR Guernsey
- CRNX United States
- Employees
- BUR N/A
- CRNX N/A
- Industry
- BUR Finance: Consumer Services
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- BUR Finance
- CRNX Health Care
- Exchange
- BUR Nasdaq
- CRNX Nasdaq
- Market Cap
- BUR 2.8B
- CRNX 2.8B
- IPO Year
- BUR 2010
- CRNX 2018
- Fundamental
- Price
- BUR $12.83
- CRNX $34.20
- Analyst Decision
- BUR Buy
- CRNX Strong Buy
- Analyst Count
- BUR 1
- CRNX 7
- Target Price
- BUR $18.00
- CRNX $74.33
- AVG Volume (30 Days)
- BUR 1.5M
- CRNX 1.1M
- Earning Date
- BUR 11-06-2025
- CRNX 11-11-2025
- Dividend Yield
- BUR 0.97%
- CRNX N/A
- EPS Growth
- BUR N/A
- CRNX N/A
- EPS
- BUR 1.08
- CRNX N/A
- Revenue
- BUR $443,251,000.00
- CRNX $1,392,000.00
- Revenue This Year
- BUR $17.08
- CRNX $489.51
- Revenue Next Year
- BUR $9.43
- CRNX $661.93
- P/E Ratio
- BUR $11.94
- CRNX N/A
- Revenue Growth
- BUR N/A
- CRNX 0.51
- 52 Week Low
- BUR $10.70
- CRNX $24.10
- 52 Week High
- BUR $15.73
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- BUR 42.34
- CRNX 58.12
- Support Level
- BUR $12.71
- CRNX $33.42
- Resistance Level
- BUR $13.10
- CRNX $37.23
- Average True Range (ATR)
- BUR 0.36
- CRNX 1.48
- MACD
- BUR -0.06
- CRNX -0.01
- Stochastic Oscillator
- BUR 24.62
- CRNX 56.59
About BUR Burford Capital Limited
Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.